Biologic agents for immune checkpoint inhibitor-associated cutaneous adverse events: a retrospective cohort study at a tertiary referral center
Published: 13 May 2026| Version 1 | DOI: 10.17632/jxf82vsjdp.1
Contributor:
Van Duc LeDescription
Supplemental File
Files
Institutions
- Mayo ClinicMinnesota, Rochester
Categories
Dermatology